Literature DB >> 24331270

Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy.

Christopher Loiselle1, Peter R Eby2, Janice N Kim3, Kristine E Calhoun4, Kimberly H Allison5, Vijayakrishna K Gadi6, Sue Peacock7, Barry E Storer8, David A Mankoff9, Savannah C Partridge10, Constance D Lehman7.   

Abstract

RATIONALE AND
OBJECTIVES: To test the ability of quantitative measures from preoperative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to predict, independently and/or with the Katz pathologic nomogram, which breast cancer patients with a positive sentinel lymph node biopsy will have four or more positive axillary lymph nodes on completion axillary dissection.
MATERIALS AND METHODS: A retrospective review was conducted to identify clinically node-negative invasive breast cancer patients who underwent preoperative DCE-MRI, followed by sentinel node biopsy with positive findings and complete axillary dissection (June 2005-January 2010). Clinical/pathologic factors, primary lesion size, and quantitative DCE-MRI kinetics were collected from clinical records and prospective databases. DCE-MRI parameters with univariate significance (P < .05) to predict four or more positive axillary nodes were modeled with stepwise regression and compared to the Katz nomogram alone and to a combined MRI-Katz nomogram model.
RESULTS: Ninety-eight patients with 99 positive sentinel biopsies met study criteria. Stepwise regression identified DCE-MRI total persistent enhancement and volume adjusted peak enhancement as significant predictors of four or more metastatic nodes. Receiver operating characteristic curves demonstrated an area under the curve of 0.78 for the Katz nomogram, 0.79 for the DCE-MRI multivariate model, and 0.87 for the combined MRI-Katz model. The combined model was significantly more predictive than the Katz nomogram alone (P = .003).
CONCLUSIONS: Integration of DCE-MRI primary lesion kinetics significantly improved the Katz pathologic nomogram accuracy to predict the presence of metastases in four or more nodes. DCE-MRI may help identify sentinel node-positive patients requiring further local-regional therapy.
Copyright © 2014 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; MRI; axilla; radiation; sentinel lymph node

Mesh:

Year:  2014        PMID: 24331270      PMCID: PMC4208879          DOI: 10.1016/j.acra.2013.10.001

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  35 in total

1.  MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.

Authors:  Savannah C Partridge; Jessica E Gibbs; Ying Lu; Laura J Esserman; Debasish Tripathy; Dulcy S Wolverton; Hope S Rugo; E Shelley Hwang; Cheryl A Ewing; Nola M Hylton
Journal:  AJR Am J Roentgenol       Date:  2005-06       Impact factor: 3.959

2.  MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.

Authors:  Lilian C Wang; Wendy B DeMartini; Savannah C Partridge; Sue Peacock; Constance D Lehman
Journal:  AJR Am J Roentgenol       Date:  2009-09       Impact factor: 3.959

3.  Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value.

Authors:  Savannah C Partridge; Wendy B DeMartini; Brenda F Kurland; Peter R Eby; Steven W White; Constance D Lehman
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

4.  Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI.

Authors:  K A Kvistad; J Rydland; H B Smethurst; S Lundgren; H E Fjøsne; O Haraldseth
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

5.  Long-term morbidity following axillary dissection in breast cancer patients--clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors.

Authors:  T Kuehn; W Klauss; M Darsow; S Regele; F Flock; C Maiterth; R Dahlbender; I Wendt; R Kreienberg
Journal:  Breast Cancer Res Treat       Date:  2000-12       Impact factor: 4.872

Review 6.  Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy.

Authors:  Mark A Zahra; Kieren G Hollingsworth; Evis Sala; David J Lomas; Li T Tan
Journal:  Lancet Oncol       Date:  2007-01       Impact factor: 41.316

7.  Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions.

Authors:  P C Stomper; J S Winston; S Herman; D L Klippenstein; M A Arredondo; L E Blumenson
Journal:  Breast Cancer Res Treat       Date:  1997-08       Impact factor: 4.872

8.  Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma.

Authors:  Laura Esserman; Nola Hylton; Tracy George; Noel Weidner
Journal:  Breast J       Date:  1999-01       Impact factor: 2.431

9.  Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging.

Authors:  S Mussurakis; D L Buckley; A Horsman
Journal:  Radiology       Date:  1997-05       Impact factor: 11.105

10.  Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.

Authors:  B Fowble; R Gray; K Gilchrist; R L Goodman; S Taylor; D C Tormey
Journal:  J Clin Oncol       Date:  1988-07       Impact factor: 44.544

View more
  7 in total

1.  Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients.

Authors:  I Barco; C Chabrera; A García-Fernández; M Fraile; S González; L Canales; J M Lain; C González; M C Vidal; E Vallejo; J Deu; A Pessarrodona; N Giménez; M García Font
Journal:  Clin Transl Oncol       Date:  2016-11-28       Impact factor: 3.405

Review 2.  Clinical Artificial Intelligence Applications: Breast Imaging.

Authors:  Qiyuan Hu; Maryellen L Giger
Journal:  Radiol Clin North Am       Date:  2021-11       Impact factor: 1.947

3.  Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: can quantitative features improve discrimination of malignant from benign?

Authors:  Habib Rahbar; Jane L Conlin; Sana Parsian; Wendy B DeMartini; Sue Peacock; Constance D Lehman; Savannah C Partridge
Journal:  Acad Radiol       Date:  2014-12-06       Impact factor: 3.173

4.  Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage.

Authors:  Elizabeth S Burnside; Karen Drukker; Hui Li; Ermelinda Bonaccio; Margarita Zuley; Marie Ganott; Jose M Net; Elizabeth J Sutton; Kathleen R Brandt; Gary J Whitman; Suzanne D Conzen; Li Lan; Yuan Ji; Yitan Zhu; Carl C Jaffe; Erich P Huang; John B Freymann; Justin S Kirby; Elizabeth A Morris; Maryellen L Giger
Journal:  Cancer       Date:  2015-11-30       Impact factor: 6.860

5.  Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat.

Authors:  J-P Obeid; R Stoyanova; D Kwon; M Patel; K Padgett; J Slingerland; C Takita; N Alperin; M Yepes; Y H Zeidan
Journal:  Clin Transl Oncol       Date:  2016-06-30       Impact factor: 3.405

6.  Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study.

Authors:  María Auxiliadora Olivares-Urbano; Carmen Griñán-Lisón; Mercedes Zurita; Rosario Del Moral; Sandra Ríos-Arrabal; Francisco Artacho-Cordón; Juan Pedro Arrebola; Amanda Rocío González; Josefa León; Juan Antonio Marchal; María Isabel Núñez
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

7.  Radiomic features of axillary lymph nodes based on pharmacokinetic modeling DCE-MRI allow preoperative diagnosis of their metastatic status in breast cancer.

Authors:  Hong-Bing Luo; Yuan-Yuan Liu; Chun-Hua Wang; Hao-Miao Qing; Min Wang; Xin Zhang; Xiao-Yu Chen; Guo-Hui Xu; Peng Zhou; Jing Ren
Journal:  PLoS One       Date:  2021-03-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.